Dual Galectin-3/EGFR-IN-1

Dual Galectin-3/EGFR-IN-1 (Compound 29) is a dual-target inhibitor with K_D values of 52.29 μM for Galectin-3 and 3.31 μM for EGFR. It demonstrates antifibrotic effects by suppressing TGF-β-induced hepatic stellate cell activation and inducing apoptosis in LX-2 cells, showing potential for liver fibrosis research.